Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
about
Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity indexPredictors of endoscopic inflammation in patients with ulcerative colitis in clinical remission"Mucosal healing" in ulcerative colitis: Between clinical evidence and market suggestion.Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes.Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials.The impact of MMX mesalazine on disease-specific health-related quality of life in ulcerative colitis patients.Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study.Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis).Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study
P2860
Q33564132-C19CDA9E-305D-4193-AC19-5A25A1243152Q34065540-35E9EB22-96D2-4970-A0C1-A5D67183D35BQ37111911-671296C5-CC7E-431D-917D-A229AAA211BEQ38217234-9B4A6A6B-6118-4B3A-9B09-4440B0C195E3Q39797507-74DC6544-A3CE-4FCC-B0C3-1C2159066471Q40520588-746C1CDB-C65D-4084-97BC-916CD4774061Q42645787-D690CFF8-367B-461A-B244-0683DDD81C62Q50026332-A508DF97-D5DE-439E-A3DB-ACB2C8FF4357Q51085282-187FB699-C168-41E9-ABF2-C22D639B282BQ55561951-E36DC748-6EFB-4AC4-9B3E-AA483A3867F4Q57171631-AD0DFAD5-0E25-43D2-A7B6-AF468FCC8FAF
P2860
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
@en
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
@nl
type
label
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
@en
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
@nl
prefLabel
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
@en
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
@nl
P2093
P356
P1476
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
@en
P2093
Bruce E Sands
Christopher S Probert
Tom J Creed
P304
P356
10.1002/IBD.22879
P577
2012-01-23T00:00:00Z